Biocides Regulations (SOR/2024-110)

Marginal note:Terms and conditions

• The following provision is not in force.

  13 (1) The Minister may, at any time, impose terms and conditions on a market authorization, or amend them, after considering

  • The following provision is not in force.

    (a) whether there are significant uncertainties relating to the benefits or risks associated with the biocide to which the authorization relates;

  • The following provision is not in force.

    (b) whether the requirements under the Act are sufficient to

    • (i) optimize the benefits and minimize the risks associated with the biocide,

    • (ii) manage the uncertainties relating to the benefits and risks, and

    • (iii) collect information to be able to continuously assess the benefits and risks, identify any changes to them and manage the uncertainties; and

  • The following provision is not in force.

    (c) whether the terms and conditions that the Minister intends to impose may contribute to meeting the objectives set out in subparagraphs (b)(i) to (iii).

• The following provision is not in force.

  Marginal note:Obligation to amend

  (2) If, after issuing a market authorization, the Minister imposes terms and conditions on the authorization or amends the terms and conditions imposed on the authorization, the Minister must

  • The following provision is not in force.

    (a) amend the authorization to reflect the terms and conditions that have been imposed or the amendment of the terms and conditions, as the case may be; and

  • The following provision is not in force.

    (b) amend the information published under subsection 12(2) accordingly.

Marginal note:Deemed creation of new biocide

14 If the holder of the market authorization for a biocide makes any of the following changes in respect of the biocide, the holder is deemed to have created a new biocide that is not authorized to be imported, sold or advertised under the authorization:

• The following provision is not in force.

  (a) the substitution, addition or removal of an active ingredient;

• The following provision is not in force.

  (b) a change to the quantity of an active ingredient that a given quantity of the biocide contains; or

• The following provision is not in force.

  (c) a change to the physical form of the biocide.

Marginal note:Major change

• The following provision is not in force.

  15 (1) It is prohibited for the holder of the market authorization for a biocide to sell any version of the biocide that is affected by a major change unless the Minister has provided the holder with a notice of acceptance in respect of the major change under subsection 16(1).

• The following provision is not in force.

  Marginal note:Content of application

  (2) An application for a notice of acceptance must be submitted to the Minister and contain

  • The following provision is not in force.

    (a) the biocide’s identification number;

  • The following provision is not in force.

    (b) a description of the major change; and

  • The following provision is not in force.

    (c) subject to subsections (3) and (6), the information referred to in subsection 10(1) to which the major change relates.

• The following provision is not in force.

  Marginal note:Conditions — application based on comparison

  (3) The information referred to in paragraph 10(1)(h), (i) and (l) — other than information relating to the net quantity of the biocide in the package, the type of its package and the properties and qualities of the packaging material — may be omitted from the application if

  • The following provision is not in force.

    (a) the application is submitted on the basis of a comparison between the version of the biocide that is affected by the major change and one of the following biocides (referred to in paragraphs (b) to (i) as “the other biocide”):

    • (i) in the case where the biocide’s market authorization was issued on the basis of an application that met the applicable conditions set out in subsection 10(2), a version of the other biocide referred to in paragraph 10(2)(a) that is also affected by the major change,

    • (ii) in the case where the biocide had been registered under the Pest Control Products Act on the basis of a comparison to the other biocide referred to in subparagraph 10(1)(o)(ii), a version of that other biocide that is also affected by the major change, or

    • (iii) in the case where a drug identification number had been assigned to the biocide under the Food and Drug Regulations on the basis of a comparison to the other biocide referred to in subparagraph 10(1)(p)(ii), a version of that other biocide that is also affected by the major change;

  • The following provision is not in force.

    (b) one of the following conditions is met in respect of the other biocide:

    • (i) in the case referred to in subparagraph (a)(i), it is the subject of a market authorization,

    • (ii) in the case referred to in subparagraph (a)(ii), it is registered under the Pest Control Products Act, or

    • (iii) in the case referred to in subparagraph (a)(iii), a drug identification number has been assigned to it under the Food and Drug Regulations and has not been cancelled;

  • The following provision is not in force.

    (c) the application contains the following information in respect of the other biocide:

    • (i) in the case referred to in subparagraph (a)(i), its identification number,

    • (ii) in the case referred to in subparagraph (a)(ii), the registration number assigned to it under the Pest Control Products Act, or

    • (iii) in the case referred to in subparagraph (a)(iii), the drug identification number assigned to it under the Food and Drug Regulations;

  • The following provision is not in force.

    (d) the application contains information that demonstrates that

    • (i) for a given quantity of biocide, the version of the biocide that is affected by the major change contains the same active ingredients in the same quantities as the other biocide,

    • (ii) the formulants that the version of the biocide that is affected by the major change contains are among the formulants that the other biocide may contain under the applicable authorization referred to in subparagraph (b)(i), (ii) or (iii),

    • (iii) for a given quantity of biocide, the quantity of each formulant that the version of the biocide that is affected by the major change contains is the same as the quantity of that formulant that the other biocide may contain under the applicable authorization referred to in subparagraph (b)(i), (ii) or (iii),

    • (iv) subject to subparagraph (v), the conditions of use of the version of the biocide that is affected by the major change fall within the conditions of use of the other biocide, and

    • (v) the version of the biocide that is affected by the major change has the same risk information and directions for storage as the other biocide;

  • The following provision is not in force.

    (e) the application contains, if the applicant is not the holder of the applicable authorization referred to in subparagraph (b)(i), (ii) or (iii) for the other biocide, an attestation, by an individual who has authority to bind the holder, that

    • (i) confirms that either

      • (A) the major change resulted in an amendment to the master formula for the other biocide and the holder provided the applicant with the updated master formula for the other biocide, or

      • (B) the major change did not result in an amendment to the master formula for the other biocide, and

    • (ii) mentions, in respect of the other biocide, its brand names and the applicable information referred to in subparagraph (c)(i), (ii) or (iii);

  • The following provision is not in force.

    (f) the application contains an attestation, by an individual who has authority to bind the applicant, that confirms that

    • (i) if the major change resulted in an amendment to the master formula for the other biocide, the version of the biocide that is affected by the major change will be manufactured in accordance with the updated master formula for the other biocide, and

    • (ii) the specifications for the version of the biocide that is affected by the major change — other than in respect of the net quantity of the biocide in the package, the type of its package and the properties and qualities of the packaging material — are the same as those for the other biocide;

  • The following provision is not in force.

    (g) in the case referred to in subparagraph (a)(i),

    • (i) the Minister has provided to the holder of the market authorization for the other biocide a notice of acceptance in respect of the major change, and

    • (ii) the other biocide’s market authorization is not suspended;

  • The following provision is not in force.

    (h) in the cases referred to in subparagraph (a)(ii) and subsection (4), the other biocide was not registered under the Pest Control Products Act on the basis of a comparison to a third biocide that is a pest control product; and

  • The following provision is not in force.

    (i) in the cases referred to in subparagraph (a)(iii) and subsection (5), the drug identification number assigned to the other biocide under the Food and Drug Regulations was not assigned on the basis of a comparison to a third biocide.

• The following provision is not in force.

  Marginal note:Deemed comparison — Pest Control Products Act

  (4) For the purposes of subparagraph (3)(a)(i), if a biocide that was exempted from the application of these Regulations under subsection 66(1) was registered under the Pest Control Products Act on the basis of a comparison to another biocide that is a pest control product and that other biocide is the subject of a market authorization, the following rules apply:

  • The following provision is not in force.

    (a) the biocide’s market authorization is deemed to have been issued on the basis of an application that met the applicable conditions set out in subsection 10(2); and

  • The following provision is not in force.

    (b) that other biocide is deemed to be the other biocide referred to in paragraph 10(2)(a).

• The following provision is not in force.

  Marginal note:Deemed comparison — Food and Drug Regulations

  (5) For the purposes of subparagraph (3)(a)(i), if a biocide that was exempted from the application of these Regulations under subsection 68(1) had been assigned a drug identification number under the Food and Drug Regulations on the basis of a comparison to another biocide and that other biocide is the subject of a market authorization, the following rules apply:

  • The following provision is not in force.

    (a) the biocide’s market authorization is deemed to have been issued on the basis of an application that met the applicable conditions set out in subsection 10(2); and

  • The following provision is not in force.

    (b) that other biocide is deemed to be the other biocide referred to in paragraph 10(2)(a).

• The following provision is not in force.

  Marginal note:Conditions — foreign regulatory authority

  (6) The information referred to in paragraphs 10(1)(h), (i) and (l) — other than information relating to the net quantity of the biocide in the package, the type of its package and the properties and qualities of the packaging material — may be omitted from the application if

  • The following provision is not in force.

    (a) the biocide’s market authorization was issued on the basis of an application submitted under section 26;

  • The following provision is not in force.

    (b) the application is submitted on the basis of a comparison between

    • (i) the version of the biocide that is affected by the major change; and

    • (ii) a version of the foreign biocide described in the market authorization that is also affected by the major change (referred to in paragraphs (c) to (f) as “the other foreign biocide”);

  • The following provision is not in force.

    (c) the foreign regulatory authority named in the market authorization has authorized the major change in respect of the other foreign biocide, other than on the basis of a type of application that is set out in the List of Foreign Regulatory Authorities in connection with that regulatory authority;

  • The following provision is not in force.

    (d) the name of the foreign regulatory authority appears in that List when the application is submitted;

  • The following provision is not in force.

    (e) the application contains

    • (i) evidence of the authorization provided by the foreign regulatory authority in respect of the major change, and

    • (ii) an attestation, by an individual who has authority to bind the holder of the market authorization, that confirms that the holder possesses or has immediate access to the information that was submitted to the foreign regulatory authority to obtain the authorization referred to in subparagraph (i); and

  • The following provision is not in force.

    (f) the application contains an attestation, by an individual who has authority to bind the holder of the market authorization, that

    • (i) confirms that either

      • (A) the major change resulted in an amendment to the master formula for the other foreign biocide and the version of the biocide that is affected by the major change will be manufactured in accordance with the updated master formula for the other foreign biocide, or

      • (B) the major change did not result in an amendment to the master formula for the other foreign biocide, and

    • (ii) confirms that the specifications for the version of the biocide that is affected by the major change — other than in respect of the net quantity of the biocide in the package, the type of its package and the properties and qualities of the packaging material — are the same as those for the other foreign biocide.

• The following provision is not in force.

  Marginal note:Additional information and material

  (7) The Minister may request the holder of the market authorization to provide any additional information or any material, including samples, that is necessary to enable the Minister to determine whether the notice of acceptance must be provided in respect of the major change.

• The following provision is not in force.

  Marginal note:Non-application of subsection (3)

  (8) Subsection (3) does not apply to a biocide that was exempted from the application of these Regulations under subsection 66(1) or 68(1) if the biocide’s market authorization was issued on the basis of an application submitted under section 26.

• The following provision is not in force.

  Marginal note:Definitions of applicant and holder

  (9) The following definitions apply in subsection (3).

  applicant

  applicant means the holder of a market authorization for a biocide that submits an application for a notice of acceptance in respect of a major change under subsection (2). (demandeur)

  holder

  holder

  • The following provision is not in force.

    (a) in respect of a registration under the Pest Control Products Act, has the meaning assigned by the definition registrant in subsection 2(1) of that Act; and 

  • The following provision is not in force.

    (b) in respect of a drug identification number assigned under the Food and Drug Regulations, means the person to whom the document setting out the drug identification number was issued under subsection C.01.014.2(1) of those Regulations. (titulaire)

• The following provision is not in force.

  Marginal note:Definition of authorization

  (10) In paragraphs (3)(d) and (e), authorization means any of the following:

  • The following provision is not in force.

    (a) a market authorization;

  • The following provision is not in force.

    (b) a registration under the Pest Control Products Act; or

  • The following provision is not in force.

    (c) a drug identification number that has been assigned under subsection C.01.014.2(1) of the Food and Drug Regulations and has not been cancelled.